ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy Study of Ceftolozane/Tazobactam to Treat Ventilated Nosocomial Pneumonia (MK-7625A-008) (ASPECT-NP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02070757
Recruitment Status : Active, not recruiting
First Posted : February 25, 2014
Last Update Posted : June 8, 2018
Sponsor:
Information provided by (Responsible Party):
Cubist Pharmaceuticals LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : May 15, 2018
  Estimated Study Completion Date : June 19, 2018